Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...

In the latest quarter, 4 analysts provided ratings for Omnicell OMCL, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the ...

For anyone who wants to understand Omnicell's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by US$5.2m due to unusual ...

Omnicell specializes in automated healthcare solutions, focusing on medication and supply management across the continuum of care. The company's market capitalization stood at approximately $1.85 ...